Koko Tawa Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.14 M
as on 15-12-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -61.40%
(FY 2022)
- Profit 122.00%
(FY 2022)
- Ebitda 113.32%
(FY 2022)
- Net Worth 0.13%
(FY 2022)
- Total Assets 4.71%
(FY 2022)
About Koko Tawa Healthcare Products
The Corporate was formerly known as Koko Tawa Healthcare Products Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.14 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Gupta, Sapna Gupta, and Kamla Gupta serve as directors at the Company.
- CIN/LLPIN
U74999DL2018PLC332812
- Company No.
332812
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Koko Tawa Healthcare Products Limited offer?
Koko Tawa Healthcare Products Limited offers a wide range of products and services, including Pollution Control Devices & Machines, Incinerator, Home Appliances & Kitchen Appliances, Kitchen Appliance, Vending Machines & Dispensers, Vending Machine, Buckets, Mugs & Storage Bins, Plastic Dustbin, Cookware and Cooking Utensils, Cooking Accessories.
Who are the key members and board of directors at Koko Tawa Healthcare Products?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Gupta  | Director | 19-Apr-2018 | Current |
| Sapna Gupta | Director | 14-May-2019 | Current |
| Kamla Gupta | Director | 14-May-2019 | Current |
Financial Performance and Corporate Structure Insights of Koko Tawa Healthcare Products.
Koko Tawa Healthcare Products Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 61.4% decrease. The company also saw a substantial improvement in profitability, with a 122% increase in profit. The company's net worth moved up by a moderate rise of 0.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Koko Tawa Healthcare Products?
In 2021, Koko Tawa Healthcare Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Koko Tawa Healthcare Products?
Unlock and access historical data on people associated with Koko Tawa Healthcare Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koko Tawa Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koko Tawa Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
